Assignee
FIBROGEN INC
US57 patents
Top patents by PatentIndex Score
US7323475B2Jan 29, 2008
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC97 citations98
US6992172B1Jan 31, 2006
Recombinant gelatins
FIBROGEN INC229 citations98
US7863292B2Jan 4, 2011
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC28 citations96
US7629357B2Dec 8, 2009
Nitrogen-containing heteroaryl compounds and methods of user thereof
FIBROGEN INC38 citations96
US8017625B2Sep 13, 2011
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC42 citations94
US7928120B2Apr 19, 2011
Cyanoisoquinoline compounds and methods of use thereof
FIBROGEN INC40 citations94
US7696223B2Apr 13, 2010
Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof
FIBROGEN INC54 citations94
US7405274B2Jul 29, 2008
Connective tissue growth factor antibodies
FIBROGEN INC47 citations94
US9920011B2Mar 20, 2018
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC10 citations92
US9339527B2May 17, 2016
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC7 citations92
US8883823B2Nov 11, 2014
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC20 citations92
US8765956B2Jul 1, 2014
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC19 citations92
US5925736AJul 20, 1999
Collagen-based methods and formulations for the treatment of arthritis
FIBROGEN INC29 citations91
US7871617B2Jan 18, 2011
Antibodies that bind to a portion of the VWC domain of connective tissue growth factor
FIBROGEN INC16 citations90
US7618940B2Nov 17, 2009
Fat regulation
FIBROGEN INC35 citations90
US6358741B1Mar 19, 2002
Connective tissue growth factor (CTGF) and methods of use
FIBROGEN INC40 citations85
US10894774B2Jan 19, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations84
US10882827B2Jan 5, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations84
US10626090B2Apr 21, 2020
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC6 citations84
US10092558B2Oct 9, 2018
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC3 citations84
US9708269B2Jul 18, 2017
Process for making isoquinoline compounds
FIBROGEN INC6 citations84
US9617218B2Apr 11, 2017
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC5 citations84
US9371288B2Jun 21, 2016
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC7 citations84
US9340511B2May 17, 2016
Process for making isoquinoline compounds
FIBROGEN INC16 citations84
US9115085B2Aug 25, 2015
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC12 citations84
US9000006B2Apr 7, 2015
Thienopyridine compounds, and methods of use thereof
FIBROGEN INC7 citations84
US7713986B2May 11, 2010
Compounds and methods for treatment of chemotherapy-induced anemia
FIBROGEN INC17 citations84
US10927081B2Feb 23, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations83
US9695170B2Jul 4, 2017
Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase
FIBROGEN INC5 citations83
US9271970B2Mar 1, 2016
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase
FIBROGEN INC7 citations83
US7393928B2Jul 1, 2008
Recombinant gelatins
FIBROGEN INC11 citations83
US6348329B1Feb 19, 2002
Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use
FIBROGEN INC15 citations83
US9174976B2Nov 3, 2015
Cyanoisoquinoline compounds and methods of use thereof
FIBROGEN INC9 citations82
US9149476B2Oct 6, 2015
Thiochromene derivatives as HIF hydroxylase inhibitors
FIBROGEN INC7 citations81
US11680048B2Jun 20, 2023
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC1 citations73
US10272078B2Apr 30, 2019
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC2 citations73
US10118897B2Nov 6, 2018
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC2 citations73
US9918977B2Mar 20, 2018
Crystalline forms of a prolyl hydroxylase inhibitor
FIBROGEN INC3 citations73
US9643928B2May 9, 2017
Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
FIBROGEN INC4 citations73
US11680047B2Jun 20, 2023
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC1 citations72
US9409892B2Aug 9, 2016
4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors
FIBROGEN INC6 citations71
US9387200B2Jul 12, 2016
Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity
FIBROGEN INC5 citations71
US6462063B1Oct 8, 2002
C-proteinase inhibitors
FIBROGEN INC10 citations71
US6020193AFeb 1, 2000
Recombinant C-proteinase and processes, methods and uses thereof
FIBROGEN INC7 citations70
US10039515B2Aug 7, 2018
Methods for treating idiopathic pulmonary fibrosis
FIBROGEN INC3 citations68
US6506936B1Jan 14, 2003
N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
FIBROGEN INC6 citations63
US11229637B2Jan 25, 2022
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC0 citations62
US10765672B2Sep 8, 2020
Pharmaceutical formulations of a HIF hydroxylase inhibitor
FIBROGEN INC2 citations61
US9631013B2Apr 25, 2017
Therapeutic method for pancreatic cancer
FIBROGEN INC6 citations61
US9034643B2May 19, 2015
Connective tissue growth factor antibodies
FIBROGEN INC1 citations60
Showing the top 50 of 57 patents by PatentIndex Score.